Zenzi Pharmaceutical Industries Profile
Key Indicators
- Authorised Capital ₹ 105.00 Cr
as on 09-12-2024
- Paid Up Capital ₹ 105.00 Cr
as on 09-12-2024
- Company Age 19 Year,
- Last Filing with ROC 31 Mar 2023
- Revenue -19.59%
(FY 2023)
- Profit 13.24%
(FY 2023)
- Ebitda -38.95%
(FY 2023)
- Net Worth -306.54%
(FY 2023)
- Total Assets -5.92%
(FY 2023)
About Zenzi Pharmaceutical Industries
The Corporate was formerly known as Alpha-Pharma Healthcare India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 105.00 Cr and a paid-up capital of Rs 105.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jacob Fiedler and Hrangdanglien serve as directors at the Company.
- CIN/LLPIN
U24231MH2005PTC234083
- Company No.
234083
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
- Apps
Who are the key members and board of directors at Zenzi Pharmaceutical Industries?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jacob Fiedler  | Director | 20-Dec-2005 | Current |
Hrangdanglien  | Director | 22-May-2019 | Current |
Financial Performance and Corporate Structure Insights of Zenzi Pharmaceutical Industries.
Zenzi Pharmaceutical Industries Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.59% decrease. The company also saw a substantial improvement in profitability, with a 13.24% increase in profit. The company's net worth observed a substantial decline by a decrease of 306.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenzi Pharmaceutical Industries?
In 2023, Zenzi Pharmaceutical Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Unigen Life Sciences Private LimitedActive 11 years 11 monthsJacob Fiedler and Hrangdanglien are mutual person
Alpha-Pharma Healthcare Private LimitedActive 10 years 11 monthsJacob Fiedler and Hrangdanglien are mutual person
Meghdoot Chemicals LimitedActive 54 years 3 monthsJacob Fiedler and Hrangdanglien are mutual person
- Coin Pharmaceuticals Private LimitedActive 12 years 6 months
Jacob Fiedler and Hrangdanglien are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zenzi Pharmaceutical Industries?
Unlock and access historical data on people associated with Zenzi Pharmaceutical Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenzi Pharmaceutical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenzi Pharmaceutical Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
